{"id":"probiotic-inersan","safety":{"commonSideEffects":[{"rate":null,"effect":"Mild gastrointestinal symptoms (bloating, gas)"},{"rate":null,"effect":"Transient digestive discomfort"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Probiotics work by introducing live beneficial bacteria into the gastrointestinal tract, where they colonize the gut microbiome, compete with pathogenic organisms, produce short-chain fatty acids, and strengthen the intestinal barrier. This restoration of eubiotic balance enhances local and systemic immune responses and may reduce inflammation and improve digestive function.","oneSentence":"Inersan is a probiotic formulation that restores beneficial gut microbiota to improve intestinal health and immune function.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:30:20.569Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Gastrointestinal disorders associated with dysbiosis"},{"name":"Immune support and gut health maintenance"}]},"trialDetails":[{"nctId":"NCT02203812","phase":"PHASE3","title":"Effect of Probiotic Lozenge on Gingivitis and Periodontitis","status":"COMPLETED","sponsor":"CD Pharma India Pvt. Ltd.","startDate":"2015-01","conditions":"Mild and Moderate Chronic Periodontitis","enrollment":32},{"nctId":"NCT02121665","phase":"PHASE3","title":"Efficacy of a Probiotic Lozenges in Chronic Periodontitis Patients.","status":"COMPLETED","sponsor":"CD Pharma India Pvt. Ltd.","startDate":"2014-07","conditions":"Chronic Periodontitis","enrollment":42},{"nctId":"NCT01438333","phase":"NA","title":"Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection","status":"COMPLETED","sponsor":"University of L'Aquila","startDate":"2011-09","conditions":"Chronic Periodontitis","enrollment":15},{"nctId":"NCT02174757","phase":"PHASE3","title":"Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis","status":"COMPLETED","sponsor":"CD Pharma India Pvt. Ltd.","startDate":"2014-08","conditions":"Chronic Periodontitis","enrollment":30},{"nctId":"NCT01870362","phase":"PHASE3","title":"Efficacy of a Probiotic Lozenge (Inersan) in Patients With Chronic Periodontitis","status":"COMPLETED","sponsor":"CD Pharma India Pvt. Ltd.","startDate":"2013-06","conditions":"Chronic Periodontitis","enrollment":28}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Inersan contains not less than 1 billion CFU of Lactobacillus brevis CD2"],"phase":"phase_3","status":"active","brandName":"Probiotic (Inersan)","genericName":"Probiotic (Inersan)","companyName":"CD Pharma India Pvt. Ltd.","companyId":"cd-pharma-india-pvt-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Inersan is a probiotic formulation that restores beneficial gut microbiota to improve intestinal health and immune function. Used for Gastrointestinal disorders associated with dysbiosis, Immune support and gut health maintenance.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}